Follow us on:
Breaking News
June 15, 2026
Breaking News
Breaking News
ContractPharma_Conference_2026_650x90

Harbour BioMed Wins $20 Million Patent Verdict Against Amgen

 
Harbour BioMed Wins $20 Million Patent Verdict Against Amgen

A U.S. jury has found Amgen liable for patent infringement against Harbour BioMed.
Read More >>

Headlines

Breaking News
Trials & Filings

AstraZeneca’s Truqap Approved in US in Combination for Prostate Cancer Treatment

Capivasertib can be used with abiraterone and prednisone for treatment of adults with PTEN-deficient mAPMN/S prostate cancer.

SPONSOR

Guided by Vision: Redefining OSD Development Through Foresight and Innovation

Explore how to master oral solid dose development with strategic foresight and a clear focus on four key pillars: technology and expertise, global networks, customized services, and regulatory excellence.

Breaking News
Collaborations & Alliances

Otsuka Completes Transcend Therapeutics Acquisition, Advancing Next-Gen Neuropsychiatric Treatments

Transcend will continue to operate as a wholly owned subsidiary of Otsuka America.

Breaking News
Collaborations & Alliances

PharmaEssentia Acquires Forus Therapeutics, Expanding Footprint in Canada

PharmaEssentia previously entered into a licensing agreement with Forus for the drug Besremi in 2024.

SPONSOR

Packaging Is Where Timelines Hold—or Slip

Why sponsors are taking a closer look at contract packaging as a driver of speed, control, and execution.

FederalEquipment_eBook_0326_650x250

Breaking News

Aptar Active Material Science Advances N-Sorb Technology

Offers packaging-delivered approach to nitrosamine risk mitigation.

SPONSOR

Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms

Novel APIs require innovative solutions. Download this whitepaper to learn how established lipid chemistries offer a safe, scalable approach to accelerate your next tablet formulation to market.

Featured Resources

Solution Content Center SPOTLIGHT

Sentry BioPharma Services ApS

Sentry BioPharma Services ApS (Sentry EU) is a contract service organization (CSO) which supports the life science industry throughout the drug development life cycle by offering cGMP temperature-controlled storage, distribution, logistics, and EMA compliant labeling and packaging services. Sentry EU's Qualified Person (QP) facilitates import/export of pharmaceuticals to/from the EU via QP audits, QP-to-QP agreements, and batch certification/declarations. Sentry EU’s validated software, cGMP storage and drug distribution facility, industry expertise, and stringent quality standards support pharmaceutical supply chain integrity throughout manufacturing, packaging, storage and distribution.

 

Solution Content Center SPOTLIGHT

Solvias

Solvias is a global provider of CMC analytics to the pharmaceutical and biotech industry. Our expert teams combine 25 years of experience with regulatory understanding across small molecules, biologics, and cell and gene therapies. We offer comprehensive solutions from raw materials to drug substance & product to final release testing.